Drug and biologics manufacturers looking to implement a chemistry, manufacturing and controls (CMC) postapproval change through the use of a comparability protocol (CP) should take note of an updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback